Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
FASEB Journal is Scopus-indexed (Q2, CiteScore 5.9), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by John Wiley & Sons Inc..
Checked against the index lists dated .
ISSN 0892-6638Verify ISSN ↗1530-6860Verify ISSN ↗
Publisher: John Wiley & Sons Inc.
Cost to publish: About US$3,740 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics | 115 / 357 | 67th | Q2 |
| Biotechnology | 126 / 325 | 61st | Q2 |
| Biochemistry | 178 / 448 | 60th | Q2 |
| Molecular Biology | 187 / 414 | 54th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1987–present, best quartile Q2, CiteScore 5.9.
FASEB Journal is Q2 in Genetics (rank 115 of 357), Q2 in Biotechnology (rank 126 of 325) and Q2 in Biochemistry (rank 178 of 448), by CiteScore 2025. It is ranked in 4 subject areas in all.
FASEB Journal is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.9, which places it in quartile Q2 at the 67th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.255, quartile Q1, with an H-index of 320.
The publisher lists an article processing charge of about US$3,740 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
FASEB Journal is published by John Wiley & Sons Inc. Its print ISSN is 0892-6638 and its online ISSN is 1530-6860.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
FASEB Journal has an h-index of 404 and a 2-year mean of 3.37 citations per paper (OpenAlex). Its Scopus CiteScore is 5.9, quartile Q2. On 2-year citations it ranks #118 of 353 Scopus journals in Genetics.
FASEB Journal published 1,132 papers in 2025; its busiest recent year was 2017 with 8,907. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (60.5%), United States (9.2%) and Canada (5.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 111 retracted papers are recorded (0.8 per 1,000 papers). The Problematic Paper Screener flags 3 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.